Skip to content
OpenCapital
Get started

Immunome IMNM Q1 2026 earnings

Reported May 12, 2026 · Before market open

Revenue-Miss by $222.2KDiluted EPS-$0.48Beat by $0.12
Revenue estimate$222.2K
EPS estimate-$0.60

Next report

Aug 5, 2026 (In 3 weeks)
Revenue estimate$166.7K
EPS estimate-$0.51

Financials

Q1 2026

Income statement

See full
Revenue--100%
Operating income-$59.3M-32.9%
Net income-$53.8M-29.3%
EPS (diluted)-$0.48+7.7%

Balance sheet

See full
Cash & equivalents$582.7M+126%
Total debt$3.7M-22.6%
Total equity$588.7M+91.7%
Total assets$619.8M+80.9%

Cash flow

See full
Operating cash flow-$58.6M-10.5%
CapEx$3.0M-18.1%
Free cash flow-$61.6M-8.7%

Valuation & ratios

Valuation

as of 07/10/26
See full
Market cap$2.74B+323%
Enterprise value$2.16B+470%
P/S681.8×+623×

Profitability

See full
Operating margin-5,947.9%-12,002pp
Net margin-5,593.8%-11,284pp
FCF margin-5,118.9%-8,601pp

Returns & leverage

See full
Return on equity-50.1%-10.8pp
Debt / equity0×0.0×
Current ratio21.7×+11.2×

Versus estimates

Revenue

Q2 2025$4.0MBeat by $3.2MQ1 2025$2.9MBeat by $2.5MQ4 2024$2.7MMiss by $408.9K

Diluted EPS

Q1 2026-$0.48Beat by $0.12
Q4 2025-$0.75Miss by $0.16Q3 2025-$0.65Miss by $0.08Q2 2025-$0.50Beat by $0.02Q1 2025-$0.52Beat by $0.14Q4 2024-$0.84Miss by $0.16

Ask the moment Immunome reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Immunome report Q1 2026 earnings?
Immunome (IMNM) reported Q1 2026 earnings on May 12, 2026 before market open.
What were Immunome's Q1 2026 revenue and EPS?
Immunome reported revenue of - and diluted EPS of $-0.48 for Q1 2026.
Did Immunome beat estimates in Q1 2026?
Revenue missed the consensus estimate of $222.2K by $222.2K. EPS beat the consensus estimate of $-0.60 by $0.12.
How did Immunome's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 100.0% from $2.9M a year earlier and diluted EPS grew 7.7% from $-0.52.
Where can I find Immunome's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-219367) and the 10-Q periodic report (0001193125-26-219425) directly on SEC EDGAR. The filing index links above go to sec.gov.